Blood flow measurement devices are used to measure blood perfusion and vessel patency in surgical settings. Technologies used for measuring blood flow include electromagnetic flowmeters, laser Doppler flowmeters, and ultrasound flowmeters. Advantages of these devices include non-invasiveness, portability, and ability to provide real-time measurements. With rising cardiovascular diseases, demand for such devices is increasing for diagnostic and treatment purposes.



Blood flow measurement devices are used to quantify and monitor blood flow in arteries and veins. Technologies used include Doppler ultrasound, laser Doppler, and electromagnetic tracking. These devices provide real-time measurements of blood flow volume and velocity non-invasively. They help physicians diagnose peripheral artery disease, deep vein thrombosis, and monitor bypass graft patency and blood circulation during surgeries.

The blood flow measurement devices market is estimated to be valued at US$ 639.5 million in 2023 and is expected to exhibit a CAGR of 8.8% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

 

Market key trends:

One of the key trends spurring growth of this market is the increasing prevalence of cardiovascular diseases globally. According to World Health Organization, cardiovascular diseases account for over 17 million deaths annually, which is estimated to grow to over 23 million by 2030. Growing geriatric population also prone to such conditions is augmenting demand for blood flow measurement devices for diagnostic and treatment management. Furthermore, technological advancements are allowing development of portable, precise and user-friendly blood flow measurement devices. Wearable and implantable versions are also gaining traction, enabling long term monitoring of blood circulation. New applications in sports medicine and physio therapy are further expanding opportunities.



Porter's Analysis

Threat of new entrants: New entrants face high capital requirements to enter the blood flow measurement devices market due to stringent regulatory norms. Bargaining power of buyers: Buyers have moderate bargaining power due to availability of substitutes and existence of several vendors offering similar products and services. Bargaining power of suppliers: Suppliers have moderate to low bargaining power due to presence of several component manufacturers. Threat of new substitutes: Threat of substitutes is moderate due to lack of substitute technologies that can provide real time blood flow data as effectively. Competitive rivalry: Companies compete based on product quality, reliability, product differentiation and pricing.



SWOT Analysis

Strengths: Rising healthcare expenditure worldwide and growing incidences of vascular diseases drive market growth. Weaknesses: High cost of advanced devices and shortages of trained professionals hamper market growth. Opportunities: Untapped potential in emerging economies present lucrative growth prospects. Threats: Stringent regulatory approval processes increase threat from legal consequences of inaccurate results.



Key Takeaways

The global blood flow measurement devices market is expected to witness high growth, exhibiting CAGR of 8.8% over the forecast period, due to increasing prevalence of cardiovascular diseases. North America dominated the blood flow measurement devices market in 2023, accounting for over 35% of global revenue, due to presence of advanced healthcare infrastructure and favorable reimbursement policies in the region.



Regionally Asia Pacific is anticipated to exhibit the fastest growth owing to rising patient pool, growing healthcare expenditure and increasing medical tourism. Key players operating in the blood flow measurement devices market are Arjo, Atys Medical, Compumedics Ltd., Cook Medical Inc., Deltex Medical Ltd., GF Health Products, Inc., Medistim ASA, Moor Instruments Ltd., Perimed AB, Transonic Systems, Inc., Medtronics, Biomedix Inc, AKW Medicals Inc., D E Hokanson Inc., Elcat GmBH, Flowtronics Inc., Ace Medicals, Carolina Medical Plc, and Compumedics Ltd.